Title: Evaluation of Daunorubicin as an adjuvant in Trabeculectomy

Authors: Dr Paramjeet Kaur, Dr Archana Gupta and Dr Sarabjit Singh

 DOI: https://dx.doi.org/10.18535/jmscr/v7i2.82

Abstract

Purpose of the study is to evaluate the intraocular pressure (IOP) lowering effect and ocular side effects of Daunorubicin (DNR) in drug modulated trabeculectomy.

Method: A prospective study was conducted on 50 eyes of 49 patients. Only primary open angle cases were taken up for the study. These were randomly divided into equal groups. Group I underwent modified trabeculectomy with application of 0.2mg/ml of Daunorubicin (DNR) intra operatively.  Group II underwent conventional trabeculectomy, patients were followed for six months. Parameter including visual acuity , IOP by NCT/ shiotz, slit lamp examination were performed on every visit. An IOP of 21mg Hg or less were taken as criteria for success.

Results: 48% of the patients were males and 52% females. The visual acuity was maintained at preoperative levels for all cases except two in which it improved from 6/24 top 6/18 in group I and deteriorated from 6/9 to 6/18 in one patient in group II. The final mean IOP at 24 weeks was 14.23 + 4.94 mm Hg in group I and 16.2 + 5.07 mm Hg in group II. A success rate of 92% (IOP < 20mm Hg) was obtained in S/C Daunorubicin versus 84% in  group II  at 24 weeks.

Conclusion: These results indicate primary trabeculectomy with Daunorcubicin to be associated with 92% success rate and lower mean IOP levels as compared to those undergoing Primary trabeculectomy without adjuvant Daunorubicin.

Keywords: Trabeculectomy, Daunorubicin, Intraocular Pressure (IOP).

References

  1. Ramakrishnan, Mona Khurana: Surgical Management of Glaucoma; An Indian perspective., Indian journal of Ophthalmology (2011)
  2. Cairns JE. Trabeculectomy : preliminary report of a new method. Am J Ophthalmol 1968; 66: 673-679
  3. MR Chang , Q.I. Cheng. DA LEE; Journal of ocular pharmacology -1998 libertpub.com
  4. Lee DA, Lee TC, Cortes AE, Kitada S. Effect of mithramycin, mitomycin, daunorubicin and bleomycin of human subconjuctival fibroblast attachment and proliferation. Invest Ophthalmol Vis Sci 1990; 31 (10):2136-2144
  5. Dadeya S, Kamlesh MS, Khurana C, Fatima S. Intraoperative daunorubicin in strabismus surgery. J Pediatr ophthalmol Strabismus 2002; 39(6) : 340-344.
  6. Dadeya S, Kamlesh MS, Khurana C, Fatima S. Intraoperative daunorubicin versus conjunctival autograft in primary pterygium surgery. Cornea 2002; 21(8): 766-769.
  7. Kumar A, Nainiwal S, Choudhary I, Tewari HK, Verma LK. Role of daunorubicin in inhabiting proliferative vitreoretinopathy after retinal detachment surgery. Clin Exp Ophthalmol 2002; 30(5): 348.
  8. Aggarwal , HC et al. Efficacy and safety of Daunorubicin in Glaucoma Filtration surgery .Indian ophthalmology , 1997.
  9. Jasleen et al : Low Dose Daunorubicin as an adjuvant in glaucoma filtration surgery M. S. Thesis. MAMC, Delhi 1998.
  10. Morales J, Kelleher PJ, Campbell D, Crosson CE. Effect of daunomycin implants on filtering surgery outcomes in rabbit. Curr Eye Res 1998; 17 (8): 844-850
  11. Borisuth NS, Phillips B, Krupin T. The risk profile of glaucoma filtration surgery. Curr Opin Ophthalmol 1999; 10 (2): 112-116.
  12. Jampel HD, Pasquale LR, Diebeinaido C. Hypotony maculopathy following trabeculectomy with mitomycin C.  Arch Ophthalmol 1992; 100: 1049-1080
  13. Zacharia PT, Deppermann SR, Schuman JS. Ocular hypotony after trabeculectomy with motomycin-C. Am j Ophthalmol 1993; 116 (3): 314-326.
  14. Gill R S, Shefali, Kaur G: Daunorubicin- A new  alternative in recalcitrant glaucoma filtering surgery.  All India Ophthalm-ogical Society Abstract 56th Annual Conference 1998; 90.
  15. Verma, R Sihote and HC Aggarwal : Evaluation and safety of Daunorubicin in glaucoma filtering surgery eye. (2007) 21, 784-788.
  16. Demailly P, Kretz G. Daunorubicin versus 5-fluorouracil in surgical treatment of primary open angle glaucoma: a prospective study . Int Ophthalmol 1992; 16(4-5): 367-370.
  17. Rabowsky JH, Dukes AJ, Lee DA, Leong KW. The use of bioerodible polymers and Daunorubicin in glaucoma filtering surgery. Ophthalmology 1996; 103 (5): 800-807.

Corresponding Author

Dr Sarabjit Singh

Prof. of Surgery Govt. Medical College Jammu

Add: 37 B/C Gandhi Nagar Jammu -180007 India

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.